Hepatitis B vaccination among high-risk adolescents and adults—San Diego, California, 1998–2001. MMWR, 51, 618–621. Google Scholar CDC. (2002c). Substance abuse treatment and public health: Working together to benefit injection drug users. [Fact sheet series]. US Department of Health and...
Factsheet on hepatitis C. 2022. https://www.who.int/zh/news-room/fact-sheets/detail/hepatitis-c.Accessed. Accessed 31 May 2022. WHO. Hepatitis data and statistics in the Western Pacific. Available from: https://www.who.int/westernpacific/health-topics/hepatitis/regional-hepatitis-data. ...
No new safety concerns were found with TDF, making it an effective treatment option in Chinese patients with chronic HBV. References World Health Organization. Hepatitis B Fact Sheet. Geneva: WHO; 2017. http://www.who.int/mediacentre/factsheets/fs204/en/#. Accessed 23 Aug 2018 Buti M, ...
Each epitope was weighted according to the degree of success obtained in each assay (T-cell assay, B-cell assay, or MHC assay) performed, with greater relevance being therefore given to those with better chances. We thus obtained a set of possible vaccine candidates with lengths ranging from ...
Thus, there was a lower prevalence of RASs conferring EBR resistance in Spanish patients compared to the USA. Meta-analysis suggests that NS3 RASs do not have any impact on efficacy of EBR/GZR treatment in HCV GT1 patients [144]. For OBV/PTV/r treatment, studies on HCV GT1b Japanese ...
1, 2, 20 In fact, infection is the second cause of death in these patients, more than liver disease.21 A Spanish multicenter prospective study conducted between 2003 and 2005 found no difference in the average incidence of infection between RT HCV+ versus RT HCV−, although HCV+ recipients...
including cirrhosis and liver cancer. Hepatitis B prevalence is highest in sub-Saharan Africa and East Asia, where between 5–10% of the adult population is chronically infected1(WHO, Hepatitis B, Fact sheet,http://www.who.int/mediacentre/factsheets/fs204/en/). The course of HBV infection...
HCV can cause kidney disease in four ways: (a) glomerular immune complex deposition; (b) direct viral invasion of the renal parenchyma; (c) renal complications of its extrarenal (e.g. hepatic) manifestations; and (d) nephrotoxicity of drugs used for its treatment. These mechanisms often inte...
HCV can cause kidney disease in four ways: (a) glomerular immune complex deposition; (b) direct viral invasion of the renal parenchyma; (c) renal complications of its extrarenal (e.g. hepatic) manifestations; and (d) nephrotoxicity of drugs used for its treatment. These mechanisms often inte...
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. Int. J. Mol. Sci. 2019, 20, 1358. [Google Scholar] [CrossRef] [Green Version] Caruso, S.; O’Brien, D.R.; Cleary, S.P.; Roberts, L.R.; ...